Harvard Bioscience Inc
NASDAQ:HBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Harvard Bioscience Inc
NASDAQ:HBIO
|
US |
|
Italian Wine Brands S.P.A.
MIL:IWB
|
IT |
|
E
|
Energy Resources Of Australia Ltd
OTC:EGRAF
|
AU |
|
Bank of Nova Scotia
TSX:BNS
|
CA |
|
I
|
Ichikoh Industries Ltd
TSE:7244
|
JP |
|
L
|
Lakes Blue Energy NL
OTC:LKOLF
|
AU |
|
Magic Software Enterprises Ltd
NASDAQ:MGIC
|
IL |
|
N
|
NIO Inc
SGX:NIO
|
CN |
|
American Airlines Group Inc
NASDAQ:AAL
|
US |
|
Wix.Com Ltd
NASDAQ:WIX
|
IL |
|
G
|
Gelex Group JSC
VN:GEX
|
VN |
|
M
|
MSA Safety Inc
F:M07
|
US |
|
T
|
Tocvan Ventures Corp
CNSX:TOC
|
CA |
|
S
|
Spectral AI Inc
NASDAQ:MDAI
|
US |
|
N
|
NVIDIA Corp
XMUN:NVD
|
US |
Wall St Price Targets
HBIO Price Targets Summary
Harvard Bioscience Inc
According to Wall Street analysts, the average 1-year price target for
HBIO is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HBIO's stock price target?
Price Target
6.12
USD
According to Wall Street analysts, the average 1-year price target for
HBIO is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Harvard Bioscience Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 2 years is 5%.